Efficacy of TCA Effect on Varicella Atrophic Scars

Sponsor
Shahid Beheshti University of Medical Sciences (Other)
Overall Status
Unknown status
CT.gov ID
NCT00422539
Collaborator
(none)
100
1

Study Details

Study Description

Brief Summary

This study aims to determine the efficacy of 70% trichloroacetic acid on atrophic scars of varicella

Condition or Disease Intervention/Treatment Phase
  • Drug: 70% trichloroacetic acid
Phase 2

Detailed Description

high concentration trichloroacetic acid peeling has been shown to be effective in treating and flattening the atrophic acne scars. According to the lack of an effective and low cost therapy for removing these relative common and nuisance lesions; We aimed to answer that whether we could achieve the same results from 70% TCA on atrophic varicella scars.

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Tri Chloro Acetic Acid (TCA) Effect on Atrophic Varicella Scars
Study Start Date :
Mar 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Objective Clearance(before and after photographies were taken) []

Secondary Outcome Measures

  1. Subjective Clearance(according to the patients satisfaction) []

  2. Adverse effects(assessed by clinician as erythema, pigmentary changes, scaring) []

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Atrophic varicella scar on face
Exclusion Criteria:
  • Active varicella infection

  • Active Herpetic infection

  • Previous history of keloid formation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Skin Research Center, Shohada-e Tajrish Hospital, shaheed Beheshti Medical University Tehran Iran, Islamic Republic of 198994148

Sponsors and Collaborators

  • Shahid Beheshti University of Medical Sciences

Investigators

  • Study Chair: Parviz Toossi, M.D., Skin Research Center of Shaheed Beheshti medical University
  • Principal Investigator: Behrooz Barikbin, M.D., Skin Research Center of Shaheed Beheshti Medical Universty

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00422539
Other Study ID Numbers:
  • SRC-BBA-1385-6-1
First Posted:
Jan 17, 2007
Last Update Posted:
Jan 17, 2007
Last Verified:
Jan 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 17, 2007